RSNA 2023 - Median Technologies

Median iCRO helps life sciences companies transform data into life-changing therapies. We understand what’s at stake for your business and offer unprecedented clinical trial imaging insights and expertise. Partnering with Pharma, Biotech, and CROs globally, we help improve business and patient outcomes.

Clinical Research Organizations

We transform medical images into meaningful, actionable insights to help better diagnose, treat, and monitor patients. We deploy proprietary artificial intelligence, computer vision, and signal processing technologies to develop imaging tests and services, addressing life-threatening unmet medical needs.

With iBiopsy® we are disrupting the management of serious diseases such as lung cancer, liver cancer, and NASH. We are deploying AI/ML Software as Medical Devices (SaMDs) to help health professionals diagnose patients earlier, treat them more effectively, and bring new hope. iBiopsy® is currently under development.

Median will be exhibiting at the RSNA 2023 Annual Meeting, which will take place from November 26 – 30 in Chicago. We will be so pleased to see you in person to talk about the latest advancements of our iBiopsy® AI-powered Software as a Medical Device (SaMD). Happy to see you there during the whole exhibition duration, from November 26 to 29.